Advertisement

IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemia

Annika Scheffold, Billy Michael Chelliah Jebaraj, Eugen Tausch, Johannes Bloehdorn, Paolo Ghia, Anella Yahiaoui, Anna Dolnik, Tamara Jacqueline Blätte, Lars Bullinger, Rashmi Priyadharshini Dheenadayalan, Li Li, Christof Schneider, Shih-Shih Chen, Nicholas Chiorazzi, Sascha Dietrich, Martina Seiffert, Stacey Tannheimer, Hartmut Döhner, Daniel Mertens and Stephan Stilgenbauer